
Crescent Biopharma, Inc.
CBIO·NASDAQ
Last updated as of 2026-06-26 15:19 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
CBIO stock price change
On the last trading day, CBIO stock closed at 17.88 USD, with a price change of 3.00% for the day.
Trade spot stocks (24/7)Bitget's stock quote pages provide comprehensive information on CBIO stock, including real-time prices, historical price charts, key data, price performance analysis, daily briefings, analyst forecasts, the latest news, business overviews, and financial analysis—all in one place. You can access real-time stock price information for Crescent Biopharma, Inc. (CBIO), including 24-hour price movements, historical price charts, 52-week high and low ranges, market capitalization, trading volume, and key financial metrics such as price-to-earnings ratio, quarterly revenue, and earnings per share. You can also stay up to date on Crescent Biopharma, Inc.'s stock price outlook and latest developments through analyst consensus price targets and curated news coverage. Information sources include NASDAQ stock exchange data, TradingView data, Crescent Biopharma, Inc. financial reports, analysis from leading Wall Street institutions and analysts, and articles from major financial media outlets.
CBIO key data
Previous close17.88 USD
Market cap492.99M USD
Volume15.03K
P/E ratio-
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)-12.48 USD
Net income (FY)−153.94M USD
Revenue (FY)10.84M USD
Next report dateJul 30, 2026
EPS estimate-
Revenue estimate357.14K USD USD
Shares float21.66M
Beta (1Y)1.43

Bitget ushers in the Stocks 2.0 era:
A new way to trade stocks — anytime, anywhere, 24/7.
Access Wall Street liquidity, dividend payouts, and futures margin support.
Learn moreCrescent Biopharma, Inc. overview
Sector
Health technology
Industry
Biotechnology
CEO
Joshua T. Brumm
Headquarters
Waltham
Website
crescentbiopharma.com
Founded
2024
Employees (FY)
44
Change (1Y)
+18 +69.23%
Revenue / Employee (1Y)
246.45K USD
Net income / Employee (1Y)
−3.50M USD
CBIO stock price forecast
According to technical indicators for CBIO stock, the price is likely to fluctuate within the range of 17.63–23.96 USD over the next week. Market analysts predict that the price of CBIO stock will likely fluctuate within the range of 15.61–25.83 USD over the next months.
Based on 1-year price forecasts from 37 analysts, the highest estimate is 34.59 USD, while the lowest estimate is 18.10 USD.
For more information, please see the
CBIO stock price forecast
page.
Trending stocks
Trade spot stocks on Bitget
Trade stock perps on Bitget
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
To provide deeper liquidity, a more transparent trading experience, and greater capital efficiency, Bitget officially launched its all-new spot stock product, Bitget Stocks 2.0, on June 2, 2026.
The new product is independently issued by licensed RWA protocol Reality, with Bitget providing strategic support and asset security safeguards. This marks a major upgrade to the stock trading experience.
Bitget is moving stock trading beyond the limits of traditional trading models by fully integrating stock assets into its margin and yield ecosystem.
Learn moreLatest CBIO stock news
Crescent Biopharma Inc recently disclosed that certain revenues recognized in its 2025 financial report actually originate from a $20 million upfront payment made by Kelun-Biotech under a licensing agreement between the two parties for the core asset Cr-001.
老虎证券2026-02-26 13:00:08
Diversified Energy Reports Record Year, Highlighted by Transformative Year-over-Year Growth, Strong Cash Generation, and Integration of ~$2 Billion in Acquisitions with Meaningful Synergies
Finviz2026-02-26 21:18:42
Crescent Energy (CRGY) Jumps 7.76% on Swing to Profits
Finviz2026-02-28 12:30:58
Crescent Energy (CRGY) Released Q4 2025 Earnings
Finviz2026-03-02 14:48:48
Crescent Energy recently disclosed plans to launch a private placement of convertible senior notes due 2031, with a total size of 400 millions USD.
老虎证券2026-03-02 21:20:36
Crescent Energy Company has finalized the private placement pricing of its 2.75% convertible senior notes due 2031.
老虎证券2026-03-04 05:21:45
Crescent Biopharma Announces Grants of Inducement Awards
Finviz2026-03-06 21:18:45
Crescent Energy (CRGY) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Finviz2026-03-10 23:18:46
Global Mofy Partners with Lianyungang Cultural Tourism Group to Develop Digital Cultural Tourism Benchmark Projects, with the Ecological Conservation-Themed Crescent Island Immersive Digital Exhibition Hall Debuting First
Finviz2026-03-12 12:33:48
Geron Announces Appointment of New Members to its Board of Directors
Finviz2026-03-26 12:03:45
Crescent Biopharma Announces Grants of Inducement Awards
Finviz2026-03-27 20:18:49
According to the latest filing with the U.S. Securities and Exchange Commission (SEC), Crescent Capital BDC Inc (CCAP) has announced significant changes to its fee structure.
老虎证券2026-05-13 21:40:59
According to the latest filing with the U.S. Securities and Exchange Commission (SEC), Crescent Energy's borrowing base has been reduced from $3.9 billion to $3.5 billion, with this adjustment set to take effect from April 1, 2026.
老虎证券2026-05-22 20:31:02
Crescent Energy Co has extended the maturity date of a revolving loan, according to a filing with the U.S. Securities and Exchange Commission.
老虎证券2026-05-22 20:32:07
Intel Stock’s 200% Rally Cracks as Nvidia Strikes Before a Make-or-Break Keynote
BeInCrypto2026-06-01 21:09:31
Crescent Biopharma Inc recently disclosed that certain revenues recognized in its 2025 financial report actually originate from a $20 million upfront payment made by Kelun-Biotech under a licensing agreement between the two parties for the core asset Cr-001.
老虎证券2026-02-26 13:00:08
Diversified Energy Reports Record Year, Highlighted by Transformative Year-over-Year Growth, Strong Cash Generation, and Integration of ~$2 Billion in Acquisitions with Meaningful Synergies
Finviz2026-02-26 21:18:42
Crescent Energy (CRGY) Jumps 7.76% on Swing to Profits
Finviz2026-02-28 12:30:58
Crescent Energy (CRGY) Released Q4 2025 Earnings
Finviz2026-03-02 14:48:48
Crescent Energy recently disclosed plans to launch a private placement of convertible senior notes due 2031, with a total size of 400 millions USD.
老虎证券2026-03-02 21:20:36
Crescent Energy Company has finalized the private placement pricing of its 2.75% convertible senior notes due 2031.
老虎证券2026-03-04 05:21:45





